MC2R
Basic information
Region (hg38): 18:13882044-13915707
Links
Phenotypes
GenCC
Source:
- glucocorticoid deficiency 1 (Strong), mode of inheritance: AR
- glucocorticoid deficiency 1 (Definitive), mode of inheritance: AR
- familial glucocorticoid deficiency (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Glucocorticoid deficiency 1 | AR | Endocrine | Early recognition and preventive measures and treatment related to hypoglycemia (as well as to potential infectious episodes) can be effective | Endocrine | 13616862; 4302512; 4312011; 4342294; 4349230; 238474; 2539720; 8094489; 8227361; 7627261; 12851305; 21823545; 22337906; 22814974 |
ClinVar
This is a list of variants' phenotypes submitted to
- Glucocorticoid deficiency 1 (8 variants)
- not provided (4 variants)
- Glucocorticoid Deficiency (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MC2R gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 17 | 32 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 71 | 24 | 103 | |||
Total | 10 | 6 | 91 | 16 | 25 |
Highest pathogenic variant AF is 0.000296
Variants in MC2R
This is a list of pathogenic ClinVar variants found in the MC2R region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-13882053-C-T | Glucocorticoid deficiency 1 | Uncertain significance (Jan 13, 2018) | ||
18-13882097-A-C | Glucocorticoid deficiency 1 | Benign (Jan 13, 2018) | ||
18-13882193-T-G | Glucocorticoid deficiency 1 | Likely benign (Jan 13, 2018) | ||
18-13882197-TA-T | Glucocorticoid Deficiency | Likely benign (Jun 14, 2016) | ||
18-13882198-A-G | Glucocorticoid deficiency 1 | Uncertain significance (Jan 13, 2018) | ||
18-13882199-A-G | Glucocorticoid deficiency 1 | Benign (Jan 12, 2018) | ||
18-13882216-T-C | Glucocorticoid deficiency 1 | Uncertain significance (Jan 12, 2018) | ||
18-13882231-G-C | Glucocorticoid deficiency 1 | Benign (Jan 12, 2018) | ||
18-13882302-G-A | Glucocorticoid deficiency 1 | Likely benign (Jan 12, 2018) | ||
18-13882401-T-G | Glucocorticoid deficiency 1 | Likely benign (Jan 13, 2018) | ||
18-13882487-C-A | Glucocorticoid deficiency 1 | Benign (Jan 13, 2018) | ||
18-13882560-C-T | Glucocorticoid deficiency 1 | Likely benign (Jan 13, 2018) | ||
18-13882651-G-GT | Glucocorticoid Deficiency | Uncertain significance (Jun 14, 2016) | ||
18-13882680-TCA-T | Glucocorticoid Deficiency | Uncertain significance (Jun 14, 2016) | ||
18-13882705-A-T | Glucocorticoid deficiency 1 | Benign (Jan 13, 2018) | ||
18-13882708-G-T | Glucocorticoid deficiency 1 | Uncertain significance (Jan 13, 2018) | ||
18-13882729-G-A | Glucocorticoid deficiency 1 | Benign (Jan 13, 2018) | ||
18-13882740-A-G | Glucocorticoid deficiency 1 | Benign (Jan 13, 2018) | ||
18-13882748-T-C | Glucocorticoid deficiency 1 | Benign (Jan 13, 2018) | ||
18-13882755-T-C | Glucocorticoid deficiency 1 | Uncertain significance (Jan 12, 2018) | ||
18-13882769-A-G | Glucocorticoid deficiency 1 | Uncertain significance (Jan 13, 2018) | ||
18-13882866-G-T | Glucocorticoid deficiency 1 | Benign (Jan 12, 2018) | ||
18-13882958-C-T | Glucocorticoid deficiency 1 | Uncertain significance (Jan 12, 2018) | ||
18-13883006-C-T | Glucocorticoid deficiency 1 | Likely benign (Jan 12, 2018) | ||
18-13883021-C-G | Glucocorticoid deficiency 1 | Benign (Jan 12, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MC2R | protein_coding | protein_coding | ENST00000327606 | 1 | 33664 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000307 | 0.369 | 125721 | 0 | 24 | 125745 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.00651 | 174 | 174 | 0.999 | 0.0000107 | 1974 |
Missense in Polyphen | 58 | 69.001 | 0.84056 | 842 | ||
Synonymous | -1.04 | 85 | 73.6 | 1.15 | 0.00000506 | 609 |
Loss of Function | -0.156 | 5 | 4.64 | 1.08 | 2.63e-7 | 60 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000210 | 0.000210 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000132 | 0.000132 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for corticotropin (ACTH). This receptor is mediated by G proteins (G(s)) which activate adenylate cyclase (cAMP). {ECO:0000269|PubMed:19329486, ECO:0000269|PubMed:20371771}.;
- Pathway
- Cortisol synthesis and secretion - Homo sapiens (human);Aldosterone synthesis and secretion - Homo sapiens (human);Cushing,s syndrome - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Corticotropin Activation of Cortisol Production;Peptide GPCRs;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.524
Intolerance Scores
- loftool
- 0.371
- rvis_EVS
- 0.26
- rvis_percentile_EVS
- 70.44
Haploinsufficiency Scores
- pHI
- 0.175
- hipred
- N
- hipred_score
- 0.267
- ghis
- 0.413
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.210
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mc2r
- Phenotype
- immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- placenta development;G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;adenylate cyclase-activating G protein-coupled receptor signaling pathway;neuropeptide signaling pathway
- Cellular component
- cytoplasm;plasma membrane;integral component of plasma membrane
- Molecular function
- melanocortin receptor activity;corticotropin receptor activity;protein binding